Tricyclic antidepressants in pregnancy and puerperium

Bibliography

• Evans J, Heron K, Francomb H, et al. Cohort study of depressed mood during pregnancy and after childbirth. BMJ 2001;323:257-60
   PubMed Web of Science ®Google Scholar
• Dietz PM, Williams SB, Callaghan WM, et al. Clinically identified depression before, during and after pregnancies ending in life births. Am J Psychiatry 2007;164:1515-20
   PubMed Web of Science ®Google Scholar
• Cohen LS, Altshuler LL, Harlow BL, et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA 2006;295:499-507
   PubMed Web of Science ®Google Scholar
• Freeman MP. Perinatal psychiatry: risk factors, treatment data, and specific challenges for clinical researchers. J Clin Psychiatry 2008;69:633-4
   PubMed Web of Science ®Google Scholar
• Steer RA, Scholl TO, Hediger ML, et al. Self-reported depression and negative pregnancy outcomes. J Clin Epidemiol 1992;45:1093-9
   PubMed Web of Science ®Google Scholar
• Orr ST, Miller CA. Maternal depressive symptoms and the risk of poor pregnancy outcome. Review of the literature and preliminary findings. Epidemiol Rev 1995;17:165-71
   PubMed Web of Science ®Google Scholar
• Heron J, O'Connor TG, Evans J, et al. The course of anxiety and depression through pregnancy and the postpartum in a community sample. J Affect Disord 2004;80:65-73
   PubMed Web of Science ®Google Scholar
• Murray L, Fiori-Cowley A, Hooper R, et al. The impact of postnatal depression and associated adversity on early mother-infant interactions and later infant outcome. Child Dev 1996;67:2512-12
   PubMed Web of Science ®Google Scholar
• Andrade SE, Raebel MA, Brown J, et al. Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol 2008;198:194.e1-5
   PubMed Web of Science ®Google Scholar
• Oberlander TF, Warburton W, Misri S, et al. Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data. Birth Defects Res B Dev Reprod Toxicol 2008;83:68-76
   PubMed Web of Science ®Google Scholar
• Malm H, Klaukka T, Neuvonen PJ. Risks associated with selective serotonin reuptake inhibitors in pregnancy. Obstet Gynecol 2005;106:1289-96
   PubMed Web of Science ®Google Scholar
• Wogelius P, Nørgaard M, Gislum M, et al. Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations. Epidemiology 2006;17:701-4
   PubMed Web of Science ®Google Scholar
• Davis RL, Rubanowice D, McPhillips H, et al. Risk of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy. Pharmacoepidemiol Drug Saf 2007;16:1086-94
   PubMed Web of Science ®Google Scholar
• Einarson TA, Einarson RN. Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies. Pharmacoepidemiol Drug Saf 2005;14:823-7
   PubMed Web of Science ®Google Scholar
• Einarson A, Pistelli A, DeSantis M, et al. Evaluation of the risk for congenital cardiovascular defects associated with use of paroxetine during pregnancy. Am J Psychiatry 2008;165:749-52
   PubMed Web of Science ®Google Scholar
• Alwan S, Reefhuis J, Rasmussen SA, et al. Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med 2007;356:2684-92
   PubMed Web of Science ®Google Scholar
• Louik C, Lin AE, Werler M, et al. First-trimester use of serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med 2007;356(26):2675-83
   PubMed Web of Science ®Google Scholar
• Diav-Citrin O, Shechtman S, Weinbaum D, et al. Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study. Br J Clin Pharmacol 2008;66:695-705
   PubMed Web of Science ®Google Scholar
• Oberlander TF, Warburton W, Misri S, et al. Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data. Birth Defects Res B Dev Reprod Toxicol 2008;83:68-76
   PubMed Web of Science ®Google Scholar
• Chambers CD, Hernandez-Diaz S, Van Marter LJ, et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 2006;354:579-87
   PubMed Web of Science ®Google Scholar
• Källén B, Otterblad-Olausson PO. Maternal use of selective serotonin re-uptake inhibitors and persistent pulmonary hypertension of the newborn. Pharmacoepidemiol Drug Saf 2008;17(8):801-6
   PubMed Web of Science ®Google Scholar
• Galbally M, Gentile S, Lewis AJ. Further findings linking SSRIs during pregnancy and persistent pulmonary hypertension of the newborn. Clinical implications. CNS Drugs 2012;26(10):813-22
   PubMed Web of Science ®Google Scholar
• Gentile S. Serotonin reuptake inhibitor-induced perinatal complications. Pediatr Drugs 2007;9:97-106
   PubMedGoogle Scholar
• Gentile S. On categorizing gestational birth, and neonatal complications following late in utero exposure to antidepressants. The prenatal antidepressant exposure syndrome. CNS Spectr 2010;15(3):167-85
   PubMed Web of Science ®Google Scholar
• Physician's Desk Reference; 2008
   Google Scholar
• Australian Drug Evaluation Committee. Prescribing Medicines in Pregnancy. Therapeutic Goods Administration, Commonwealth of Australia; 1999
   Google Scholar
• FDA Drug Safety Communication: Selective serotonin reuptake inhibitor (SSRI) antidepressant use during pregnancy and reports of a rare heart and lung condition in newborn babies. Available from: http://www.fda.gov/drugs/drugsafety/ucm283375.htm [Last accessed 24 July 2013]
   Google Scholar
• Health Canada advises of potential serious adverse effects of SSRIs and other antidepressants on newborns [advisory]. Ottawa: Health Canada, August 2004. Available from: http://www.cwhn.ca/en/node/42353 [Last accessed 24 July 2013]
   Google Scholar
• National Teratology Information Service. Treatment of depression in pregnancy. National Teratology Information Service, Regional Drugs and Therapeutics Centre; Newcastle upon Tyne, England; 2005
   Google Scholar
• National Institute for Health and Clinical Excellence. Antenatal and postnatal mental health, National Clinical Practice Guideline Number 45. 2007. Available from: http://www.nice.org.uk/nicemedia/pdf/CG045NICEGuidelineCorrected.pdf [Last accessed 4 January 2013]
   Google Scholar
• Jeffries WS, Bochner F. The effect of pregnancy on drug pharmacokinetics. Med J Aust 1988;49:675-7
   Google Scholar
• Krauer B. Pharmacotherapy during pregnancy: emphasis on pharmacokinetics. In: Eskes TK, Finster M, editors. Drug therapy during pregnancy. Butterworths; London: 1985. p. 9-31
   Google Scholar
• Wisner KL, Perel JM, Wheeler SB. Tricyclic dose requirements across pregnancy. Am J Psychiatry 1993;150:1541-2
   PubMed Web of Science ®Google Scholar
• Altshuler L, Hendrick V. Pregnancy and psychotropic medications: changes in blood levels [Letter]. J Clin Psychopharmacol 1996;16:78-80
   PubMed Web of Science ®Google Scholar
• Rasmussen F. The mechanism of drug secretion into milk. In: Brodie B, Gillette R, editors. Concepts in biochemical pharmacology. Volume 1. Springer-Verlag; New-York: 1973. p. 231-45
   Google Scholar
• Gentile S, Rossi A, Bellantuono C. SSRIs during breastfeeding: spotlight on milk-to-plasma ratio. Arch Women's Ment Health 2007;10:39-51
   PubMed Web of Science ®Google Scholar
• Morrow AW. Imipramine and congenital abnormalities [Letter]. NZ Med J 1972;4:228-9
   Google Scholar
• Levy L. Imipramine and fetal deformities [Letter]. CMAJ 1972;106:1057-8
   PubMed Web of Science ®Google Scholar
• McBride WG. Limb deformities associated with iminodibenzyl hydrochloride [Letter]. Med J Aust 1972;3:492
   Google Scholar
• Barson AJ. Malformed infant [Letter]. Br Med J 1972;4:45
   Google Scholar
• Idänpään-Heikkilä J, Saxen L. Possible teratogenicity of imipramine/chloropyramine. Lancet 1973;8:282-4
   Google Scholar
• McElhatton PR, Garbis HM, Elefant E, et al. The outcome of pregnancy in 689 women exposed to therapeutic doses of antidepressants. A collaborative study of the European Network of Teratology Information service. Repr Toxicol 1996;10:285-94
   PubMed Web of Science ®Google Scholar
• Kuenssemberg EV, Knox JDE. Imipramine and pregnancy [Letter]. Br Med J 1972;4:292
   Google Scholar
• Australian Drug Evaluation Committee. Tricyclic antidepressants and limb reduction deformities. Med J Aust 1973;1:768-9
   PubMed Web of Science ®Google Scholar
• Crombie DL, Pinsent RJFH, Fleming D. Imipramine and pregnancy [Letter]. Br Med J 1972;3:745
   Google Scholar
• Ware MR, DeVane L. Imipramine treatment of panic disorder during pregnancy. J Clin Psychiatry 1990;51:482-4
   PubMed Web of Science ®Google Scholar
• Misri S, Sivertz K. Tryciclic drugs in pregnancy and lactation: a preliminary report. Int J Psychiatry Med 1991;21:157-71
   PubMed Web of Science ®Google Scholar
• Eggermont E, Raveschot J, Deneve V, et al. The adverse influence of imipramine on the adaptation of the newborn infant to extrauterine life. Acta Paediatr Belg 1972;26:197-204
   PubMedGoogle Scholar
• Webster PAC. Withdrawal symptoms in neonates associated with maternal antidepressant therapy [Letter]. Lancet 1973;8:318-19
   Google Scholar
• Yoshida K, Smith B, Craggs M, et al. Investigation of pharmacokinetics and of possible adverse effects in infants exposed to tricyclic antidepressants in breast-milk. J Affect Disord 1997;43:225-37
   PubMed Web of Science ®Google Scholar
• Birnbaum CS, Cohen LS, Bailey JW, et al. Serum concentrations of antidepressants and benzodiazepines in nursing infants: a case series. Pediatrics 1999;104:e11
   PubMedGoogle Scholar
• Sovner R, Orsulak PJ. Excretion of imipramine and desipramine in human breast milk. Am J Psychiatry 1979;136:451-2
   PubMed Web of Science ®Google Scholar
• Stancer HC, Reed KL. Desipramine and 2-hydroxydesipramine in human breast milk and infant's serum. Am J Psychiatry 1896;143:597-600
   Google Scholar
• Maschi S, Clavenna A, Campi R, et al. Neonatal outcome following pregnancy exposure to antidepressants: a prospective controlled cohort study. BJOG 2008;115(2):283-9
   PubMed Web of Science ®Google Scholar
• Freeman R. Limb deformities: possible association with drugs [Letter]. Med J Aust 1972;3:606-7
   Google Scholar
• Rafla NM, Meehan FP. Thanatophoric dwarfism; drugs and antenatal diagnosis; a case-report. Eur J Obstet Gynecol Reprod Biol 1990;38:161-5
   Web of Science ®Google Scholar
• Golden AM, Perman KI. Bilateral clinical anophthalmia: drugs as potential factors. South Med J 1980;73(10):1404-7
   PubMed Web of Science ®Google Scholar
• Breyer-Pfaff U, Karl N, Entermann A, et al. Secretion of amitriptyline and metabolites into breast milk. Am J Psychiatry 1995;152:812-13
   PubMed Web of Science ®Google Scholar
• Hendrick V, Altshuler LL. Management of breakthrough panic disorder symptoms during pregnancy [Letter]. J Clin Psychopharmacol 1999;17:228-9
   Web of Science ®Google Scholar
• Shearer WT, Schreiner RL, Marshall RE. Urinary retention in a neonate secondary to maternal ingestion of nortriptyline. J Pediatr 1972;81:570-2
   PubMed Web of Science ®Google Scholar
• Bader TF, Newman K. Amitriptyline in human breast milk and the nursing infant's serum. Am J Psychiatry 1980;137:855-6
   PubMed Web of Science ®Google Scholar
• Brixen-Rasmussen L, Halgrener J, Jorgensen A. Amitriptyline and nortriptyline excretion in human breast milk. Psychopharmacology 1982;76:94-5
   PubMed Web of Science ®Google Scholar
• Pittard WB III, O'Neal W Jr. Amitriptyline excretion in human milk. J Clin Psychopharmacol 1986;6:383-4
   PubMed Web of Science ®Google Scholar
• Erickson SH, Smith GH, Heidrich F. Tryciclics and breastfeeding [Letter]. Am J Psychiatry 1979;136:1483
   PubMedGoogle Scholar
• Wisner KL, Perel JM. Serum nortriptyline levels in nursing mothers and their infants. Am J Psychiatry 1991;148:1234-6
   PubMed Web of Science ®Google Scholar
• Wisner KL, Perel JM. Nortriptyline treatment of breastfeeding women [Letter]. Am J Psychiatry 1996;153:295
   PubMedGoogle Scholar
• Wisner KL, Perel JM, Findling RL, Hinnes RL. Nortriptyline and its hydroxymetabolites in breastfeeding mothers and newborns. Psychopharmacol Bull 1997;33:249-51
   PubMed Web of Science ®Google Scholar
• Matheson I, Skjaeraasen J. Milk concentrations of flupenthixol, nortriptyline and zuclopenthixol and between-breast difference in two patients. Eur J Clin Pharmacol 1988;35:217-20
   PubMed Web of Science ®Google Scholar
• Mammen O, Perel JM, Wheeler S. Antidepressants and breastfeeding. Am J Psychiatry 1997;154:1174-5
   PubMedGoogle Scholar
• Schimmell MS, Zylber Katz E, Shaag Y, et al. Toxic neonatal effects following maternal clomipramine therapy. J Toxicol Clin Toxicol 1991;29:479-84
   PubMed Web of Science ®Google Scholar
• Källén B. Antidepressant drugs during pregnancy and infant congenital hearth defects [Letter]. Reprod Toxicol 2006;21:221-2
   PubMed Web of Science ®Google Scholar
• Källén B, Otterblad Olausson P. Maternal drug use in early pregnancy and infant cardiovascular defects. Reprod Toxicol 2003;17:255-61
   PubMed Web of Science ®Google Scholar
• Ben Musa A, Smith CS. Neonatal effects of maternal clomipramine therapy [Letter]. Arch Dis Child 1979;54(5):405
   Web of Science ®Google Scholar
• Cowe L, Lloyd DJ, Dawling S. Neonatal convulsions caused by withdrawal from maternal clomipramine. Br Med J 1982;284:1837-8
   PubMed Web of Science ®Google Scholar
• Østergaard GZ, Pedersen SE. Neonatal effects of maternal clomipramine therapy. Pediatrics 1982;69(2):233-4
   PubMed Web of Science ®Google Scholar
• Singh S, Gulati S, Narang A, et al. Non-narcotic withdrawal syndrome in a neonate due to maternal clomipramine therapy [Letter]. J Paediatr Child Health 1990;26(2):110
   PubMed Web of Science ®Google Scholar
• Bromiker R, Kaplan M. Apparent intrauterine fetal withdrawal from clomipramine hydrochloride [Letter]. JAMA 1994;272(22):1722-3
   PubMed Web of Science ®Google Scholar
• Bloem BR, Lammers GJ, Roofhooft DWE, et al. Clomipramine withdrawal in newborns [Letter]. Arch Dis Child Fetal Neonatal Ed 1999;81:F77-9
   PubMed Web of Science ®Google Scholar
• ter Horst PGJ, van der Linde S, Smit JP, et al. Clomipramine concentration and withdrawal symptoms in 10 neonates. Br J Clin Pharmacol 2011;73(2):295-302
   Web of Science ®Google Scholar
• Wisner KL, Perel JM, Foglia JP. Serum clomipramine and metabolite levels in four nursing mother-infant pairs. J Clin Psychiatry 1995;56:17-20
   PubMed Web of Science ®Google Scholar
• Prentice MA, Brown R. Fetal tachyarrhythmia and maternal antidepressant treatment [Letter]. Br Med J 1989;298:190
   PubMed Web of Science ®Google Scholar
• Ilett KF, Lebedevs TH, Wojnar-Horton RE, et al. The excretion of dothiepin and its primary metabolites in breast milk. Br J Clin Pharmacol 1992;33:635-9
   PubMed Web of Science ®Google Scholar
• Buist A, Norman T, Dennerstein L. Plasma and breast milk concentrations of dothiepin and northiaden in lactating women. Hum Psychopharmol 1993;8:29-33
   Web of Science ®Google Scholar
• Matheson I, Pande H, Alertsen AR. Respiratory depression caused by N-desmethyldoxepin in breast milk [Letter]. Lancet 1985;11:1124
   Google Scholar
• Frey OR, Scheidt P, von Brenndorff AI. Adverse effects in a newborn infant breast-fed by a mother treated with doxepin. Ann Pharmacother 1999;8:690-3
   Google Scholar
• Kemp J, Ilett KF, Booth J, et al. Excretion of doxepin and N-desmethyldoxepin in human milk. Br J Clin Pharmacol 1985;20:497-9
   PubMed Web of Science ®Google Scholar
• Pastuszac A, Schick-Boschetto B, Zuber C, et al. Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac). JAMA 1993;269(17):2246-8
   PubMed Web of Science ®Google Scholar
• Nulman I, Rovet J, Stewart DE, et al. Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 1997;336:258-62
   PubMed Web of Science ®Google Scholar
• Simon GE, Cunningham ML, Davis RL. Outcomes of prenatal antidepressant exposure. Am J Psychiatry 2002;159:2055-61
   PubMed Web of Science ®Google Scholar
• Vasilakis-Scaramozza C, Aschengrau A, Cabral H, Jick SS. Antidepressant use during early pregnancy and the risk of congenital anomalies. Pharmacotherapy 2013;33(7):693-700
   PubMed Web of Science ®Google Scholar
• Reis M, Källén B. Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data. Psychol Med 2010;40(10):1723-33
   PubMed Web of Science ®Google Scholar
• Palmsten K, Huybrechts KF, Michels KB, et al. Antidepressant use and risk for preeclampsia. Epidemiology 2013;24(5):682-91
   PubMed Web of Science ®Google Scholar
• Källén B. Neonate characteristics after maternal use of antidepressants in late pregnancy. Arch Pediatr Adolesc Med 2004;158:312-16
   PubMed Web of Science ®Google Scholar
• Nulman I, Rovet J, Stewart DE, et al. Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am J Psychiatry 2002;159:1889-95
   PubMed Web of Science ®Google Scholar
• Rai D, Lee BK, Dalman C, et al. Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study. BMJ 2013;346:f2059
   PubMed Web of Science ®Google Scholar
• Gentile S. On categorizing gestational birth, and neonatal complications following late in utero exposure to antidepressants. The prenatal antidepressant exposure syndrome. CNS Spectrums 2010;15(3):167-85
   PubMed Web of Science ®Google Scholar
• Gentile S. Use of contemporary antidepressants during breastfeeding. A proposal for a specific safety index. Drug Saf 2007;30:107-21
   PubMed Web of Science ®Google Scholar
• Nelson K, Holmes LG. Malformations due to presumed spontaneous mutations in newborn infants. N Engl J Med 1989;320:19-23
   PubMed Web of Science ®Google Scholar
• Dubnov-Raz Juurlink DN, Fogelman R, et al. Antenatal use of serotonin-reuptake inhibitors and QT interval prolongation in newborns. Pediatrics 2008;122(3):e710-15
   PubMed Web of Science ®Google Scholar
• Stiskal JA, Kulin N, Koren G, et al. Neonatal paroxetine withdrawal syndrome. Arch Dis Child Fetal Neonatal Ed 2001;84:F134-5
   PubMed Web of Science ®Google Scholar